KM02894
Product Specifications
UNSPSC Description
KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/km02894.html
Purity
99.31
Solubility
DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)|DMSO : 33.33 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
CNC(NNC(C1=CC=CS1)=O)=S
Molecular Weight
215.30
References & Citations
[1]Fazzari J, et.al. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015 Feb 11;5:8380.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-W276106/KM02894-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W276106/KM02894-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
116850-74-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1383842-01 0.02 mg (E-Coli)
Recombinant Pseudoalteromonas haloplanktis UPF0246 protein PSHAa2558 (PSHAa2558)
Ask
View Details MBS1383842-02 0.02 mg (Yeast)
Recombinant Pseudoalteromonas haloplanktis UPF0246 protein PSHAa2558 (PSHAa2558)
Ask
View Details